Literature DB >> 27770334

Secondary balloon kyphoplasty for new vertebral compression fracture after initial single-level balloon kyphoplasty for osteoporotic vertebral compression fracture.

Dawei Song1, Bin Meng1, Guangdong Chen1, Junjie Niu1, Weimin Jiang1, Zongping Luo2, Huilin Yang3.   

Abstract

PURPOSE: To explore the efficacy of secondary balloon kyphoplasty (BKP) for new vertebral compression fracture (NVCF) of previously non-fractured, non-treated vertebrae after previous BKP and to compare the therapeutic effect between patients with single-level adjacent NVCF and remote NVCF.
METHODS: We retrospectively studied patients with single-level NVCF after initial BKP in our hospital from January 2007 to August 2014. The mean follow-up time from secondary BKP was 13.78 ± 3.18 (12-24) months. Visual analog scale (VAS) and Oswestry disability index (ODI) scores were assessed prior to the initial BKP, one day after initial BKP, prior to the secondary BKP, one day after the secondary BKP, and at last follow-up. Kyphotic angle and vertebral heights were also compared for secondary BKP. Data were compared between patients with adjacent NVCF and remote NVCF.
RESULTS: 36 patients were investigated. Compared with pre-operative value of initial and secondary BKP, patients in both groups gained statistical significant improvements for VAS and ODI after initial and secondary BKP, respectively (P < 0.05), and this improvement maintained at final follow-up. No statistical difference in VAS was found between the 2 groups after initial BKP and prior to the secondary BKP (P > 0.05), but patients in remote NVCF group achieved better VAS score than patients in adjacent NVCF group after the secondary BKP and at the final follow-up (P < 0.05). No statistical differences were detected in ODI between the 2 groups prior to the initial BKP, one day after initial BKP, prior to the secondary BKP and 1 day after the secondary BKP (P > 0.05), but the ODI scores were higher in adjacent NVCF group than in remote NVCF at last follow-up (P < 0.05). Kyphotic angle and vertebral heights were significantly restored and maintained after secondary BKP within groups, respectively.
CONCLUSIONS: Secondary BKP is an effective procedure for treating NVCF after initial BKP. Patients with new fracture in remote level gain slightly better pain relief than those in the adjacent level.

Entities:  

Keywords:  Adjacent and remote level; Oswestry disability index; Secondary balloon kyphoplasty; Subsequent new vertebral compression fracture; Visual analog scale

Mesh:

Year:  2016        PMID: 27770334     DOI: 10.1007/s00586-016-4784-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  31 in total

1.  Risk factors predicting the new symptomatic vertebral compression fractures after percutaneous vertebroplasty or kyphoplasty.

Authors:  Young-Joon Rho; Woo Jin Choe; Young Il Chun
Journal:  Eur Spine J       Date:  2011-12-09       Impact factor: 3.134

Review 2.  Comparison of Percutaneous Vertebroplasty and Balloon Kyphoplasty for the Treatment of Single Level Vertebral Compression Fractures: A Meta-analysis of the Literature.

Authors:  Hua Wang; Shilabant Sen Sribastav; Fubiao Ye; Cangsheng Yang; Jianru Wang; Hui Liu; Zhaomin Zheng
Journal:  Pain Physician       Date:  2015 May-Jun       Impact factor: 4.965

3.  Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures.

Authors:  I H Lieberman; S Dudeney; M K Reinhardt; G Bell
Journal:  Spine (Phila Pa 1976)       Date:  2001-07-15       Impact factor: 3.468

4.  Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures.

Authors:  Majid Reza Farrokhi; Ehsanali Alibai; Zohre Maghami
Journal:  J Neurosurg Spine       Date:  2011-03-04

5.  Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12-month randomized follow-up, controlled trial.

Authors:  Jordi Blasco; Angeles Martinez-Ferrer; Juan Macho; Luis San Roman; Jaume Pomés; Josep Carrasco; Ana Monegal; Nuria Guañabens; Pilar Peris
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

6.  Repeat vertebroplasty for unrelieved pain at previously treated vertebral levels with osteoporotic vertebral compression fractures.

Authors:  Shi-Cheng He; Gao-Jun Teng; Gang Deng; Wen Fang; Jin-He Guo; Guang-Yu Zhu; Guo-Zhao Li
Journal:  Spine (Phila Pa 1976)       Date:  2008-03-15       Impact factor: 3.468

7.  Incidence of symptomatic vertebral fractures in patients after percutaneous vertebroplasty.

Authors:  Johannes Hierholzer; Heiko Fuchs; Kerstin Westphalen; Clemens Baumann; Christine Slotosch; Rudolf Schulz
Journal:  Cardiovasc Intervent Radiol       Date:  2008-07-01       Impact factor: 2.740

8.  The effect of cement augmentation on the load transfer in an osteoporotic functional spinal unit: finite-element analysis.

Authors:  Anne Polikeit; Lutz Peter Nolte; Stephen J Ferguson
Journal:  Spine (Phila Pa 1976)       Date:  2003-05-15       Impact factor: 3.468

9.  A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.

Authors:  Rachelle Buchbinder; Richard H Osborne; Peter R Ebeling; John D Wark; Peter Mitchell; Chris Wriedt; Stephen Graves; Margaret P Staples; Bridie Murphy
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

10.  Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study.

Authors:  Rikke Rousing; Mikkel O Andersen; Stig M Jespersen; Karsten Thomsen; Jens Lauritsen
Journal:  Spine (Phila Pa 1976)       Date:  2009-06-01       Impact factor: 3.468

View more
  1 in total

1.  Cement bridging phenomenon in percutaneous vertebroplasty for adjacent vertebral compression fracture.

Authors:  Yun-Da Li; Tsung-Ting Tsai; Chi-Chien Niu; Po-Liang Lai
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.